ARGUS downgrades The Medicines Co. (Nasdaq: MDCO) from Buy to Hold.

ARGUS analyst says, "Although the shares are ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE